These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 17661525)

  • 1. Proton-pump inhibitor therapy in patients with gastro-oesophageal reflux disease: putative mechanisms of failure.
    Fass R
    Drugs; 2007; 67(11):1521-30. PubMed ID: 17661525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.
    Miner PB
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():25-32. PubMed ID: 16483267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of heartburn not responding to proton pump inhibitors.
    Fass R; Sifrim D
    Gut; 2009 Feb; 58(2):295-309. PubMed ID: 19136523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease.
    Zerbib F; Belhocine K; Simon M; Capdepont M; Mion F; Bruley des Varannes S; Galmiche JP
    Gut; 2012 Apr; 61(4):501-6. PubMed ID: 21997546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of proton pump inhibitors in gastro-oesophageal reflux disease.
    Dekel R; Morse C; Fass R
    Drugs; 2004; 64(3):277-95. PubMed ID: 14871170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of PPI-resistant gastro-oesophageal reflux: A systematic review.
    Gallusi G; Pontone S
    Arab J Gastroenterol; 2018 Jun; 19(2):51-55. PubMed ID: 29935866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG; Berstad A
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractory gastrooesophageal reflux disease.
    Bredenoord AJ; Smout AJ
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):217-23. PubMed ID: 18301303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of potent acid inhibition in gastro-oesophageal reflux disease.
    Monés J
    Drugs; 2005; 65 Suppl 1():35-42. PubMed ID: 16335856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring.
    Mainie I; Tutuian R; Shay S; Vela M; Zhang X; Sifrim D; Castell DO
    Gut; 2006 Oct; 55(10):1398-402. PubMed ID: 16556669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitor failure in gastro-oesophageal reflux disease: a perspective aided by the Gartner hype cycle.
    Heading RC
    Clin Med (Lond); 2017 Apr; 17(2):132-136. PubMed ID: 28365622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitor failure--what are the therapeutic options?
    Fass R
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S33-8. PubMed ID: 19262545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease.
    Kahrilas PJ; Hughes N; Howden CW
    Gut; 2011 Nov; 60(11):1473-8. PubMed ID: 21508423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: acidity and volume of the refluxate in the genesis of gastro-oesophageal reflux disease symptoms.
    Sifrim D; Mittal R; Fass R; Smout A; Castell D; Tack J; Gregersen H
    Aliment Pharmacol Ther; 2007 May; 25(9):1003-17. PubMed ID: 17439501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weakly acidic reflux.
    Tack J; Blondeau K
    Dig Dis; 2009; 27(1):58-61. PubMed ID: 19439962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of proton-pump inhibitor-refractory non-erosive reflux disease according to multichannel intraluminal impedance-pH monitoring.
    Kohata Y; Fujiwara Y; Machida H; Okazaki H; Yamagami H; Tanigawa T; Watanabe K; Watanabe T; Tominaga K; Arakawa T
    J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():58-62. PubMed ID: 22486873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease--where next?
    Fass R; Shapiro M; Dekel R; Sewell J
    Aliment Pharmacol Ther; 2005 Jul; 22(2):79-94. PubMed ID: 16011666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of reflux inhibitors in clinical trials: bad drugs or wrong patients?
    Kahrilas PJ; Boeckxstaens G
    Gut; 2012 Oct; 61(10):1501-9. PubMed ID: 22684485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review: Is there excessive use of proton pump inhibitors in gastro-oesophageal reflux disease?
    Lee TJ; Fennerty MB; Howden CW
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1241-51. PubMed ID: 15606386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased swallowing frequency in GORD is likely to be caused by perception of reflux episodes.
    Hemmink GJ; Weusten BL; Bredenoord AJ; Timmer R; Smout AJ
    Neurogastroenterol Motil; 2009 Feb; 21(2):143-8. PubMed ID: 19019017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.